SMN1 and breast carcinoma: In breast carcinoma, recent data suggest that CD34 fibrocytes undergo morphologic and phenotypic alterations characterized by the adoption of a plump myofibroblast-like appearance and loss of CD34 expression, accompanied by the acquisition of α-smooth muscle actin (SMA) expression [5].